Syngene Large Molecule Bioanalytical Laboratory
Explore Syngene’s Large Molecule Bioanalytical Laboratory, which is India’s premier GLP- certified and GCLP-compliant lab. It specializes in immunogenicity and pharmacokinetic (PK) analysis of biologics and biosimilars.
Syngene Discovery Chemistry facility, Hyderabad
Explore our new 52,000 sq. ft., state-of-the-art R&D center in Genome valley, Hyderabad. Focused on Discovery Chemistry services, we are excited to be expanding our facilities to assist more clients accelerate their research programs.
Syngene’s early-stage Chemistry Process Research lab for drug discovery
Watch this video on our early-stage Chemistry Process Research lab for drug discovery that supports pre-clinical studies, medicinal chemistry, and integrated project requirements (from mg to kg scale).
Syngene’s Sterile Fill-Finish facility for Clinical Supplies – Biologics & Small Molecules
In this video, Syngene scientist Saurabh Sahu takes you through the capabilities and features of our integrated Sterile Fill-Finish facility for clinical supplies of Biologics and Small Molecules, as well as, products that are sensitive to light, heat and oxygen.
Syngene COVID-19 Testing Center using qRT-PCR
Want to know, how Syngene conducts RT-PCR testing at its COVID-19 Testing laboratory? Approved by Indian Council of Medical Research (ICMR), this lab has tested more than 100000+ samples so far.
Annual Report 2023: Exceptional partnerships, dynamic growth
Watch this video to catch a glimpse of the incredible milestones we have achieved over the past year. Explore how we are shaping the future of science and medicine with our collaborative partnerships based on the foundation of common interest, shared commitment, complementary skills, and desire to work together. To know more about the innovative […]
CFO Sibaji Biswas’ year-end reflections and outlook for FY24
Watch this video where our CFO, Sibaji Biswas, shares his perspective on a trend-breaking year with revenue growth of 23% year-on-year. Syngene delivered the highest absolute year-on-year increase in revenue and EBITDA compared to the last five years. While the research business and Dedicated Centers delivered a strong performance, Development and Manufacturing services grew by […]
MD & CEO Jonathan Hunt’s year-end reflections and outlook for FY24
Watch this video where our MD and CEO, Jonathan Hunt, shares his perspective on the financial year gone by, and the outlook for FY24. Syngene’s sustained positive performance in the fourth quarter delivered strong full-year results. Revenue from operations in Q4 grew by 31%, while full-year revenue from operations in FY 23 grew by 23%. […]
Life at Syngene: Spotlight on Computational & Data Sciences with Dr. Achintya Das
Watch this video of Dr. Achintya Das, Head of Computational & Data Sciences, speaking about Syngene’s proprietary modeling and AI solutions which help scientists make informed decisions across phases of drug discovery. He also talks about Syngene’s virtual liver platform, HepTox, used for mechanistic assessment of exposure-dependent hepatotoxicity.
Life at Syngene: Spotlight on Discovery Biology with Dr. Jayashree Aiyar
Watch this video where our VP and Head of Discovery Biology, Dr. Jayashree Aiyar, speaks about her journey at Syngene and how the biotech industry has evolved over the last few years. An industry veteran with 25 years of experience, she highlights key research areas that global pharma and biotechs are currently focusing on, including […]
